Clearline Capital LP Nautilus Biotechnology, Inc. Transaction History
Clearline Capital LP
- $3.49 Billion
- Q2 2024
A detailed history of Clearline Capital LP transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Clearline Capital LP holds 164,073 shares of NAUT stock, worth $442,997. This represents 0.01% of its overall portfolio holdings.
Number of Shares
164,073
Previous 168,984
2.91%
Holding current value
$442,997
Previous $496,000
22.78%
% of portfolio
0.01%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding NAUT
# of Institutions
81Shares Held
63.8MCall Options Held
2.9KPut Options Held
500-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$44 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$34 Million0.85% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$19.4 Million0.45% of portfolio
-
Madrona Venture Group, LLC6.02MShares$16.3 Million15.03% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$10.3 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $337M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...